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Supra-­‐physiological	  doses	  of	  testosterone	  affect	  membrane	  
oxidation	  of	  human	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  monitored	  by	  the	  fluorescent	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Abstract	  The	  purpose	  of	  this	  study	  was	  to	  determine	  the	  effects	  of	  supra-­‐physiological	  doses	  of	  testosterone	  (TES)	  on	  membrane	  oxidation	  of	  activated	  human	  neutrophils	  in	  vitro	  using	  an	  innovative	  and	  sensitive	  technique:	  the	  real-­‐time	  detection	  with	  the	  fluorescence	  probe	  C11-­‐BODIPY581/591.	  Methodological	  controls	  were	  performed	  with	  the	  lipid-­‐soluble	  and	  powerful	  antioxidant	  astaxanthin	  at	  different	  neutrophil	  density	  cultures.	  Neutrophils	  from	  nine	  healthy	  young	  men	  (23.4	  ±	  2.5	  years,	  174.4	  ±	  7.0	  cm	  height,	  and	  78.3	  ±	  7.0	  kg	  weight)	  were	  isolated	  and	  treated	  with	  0.1	  or	  10	  μM	  TES	  for	  24	  h	  and	  subsequently	  labeled	  with	  the	  free	  radical-­‐sensitive	  probe	  C11-­‐BODIPY581/591	  for	  monitoring	  membrane	  oxidation	  after	  neutrophil	  activation	  with	  phorbol-­‐12-­‐myristate-­‐13-­‐acetate	  (PMA).	  First-­‐order	  exponential	  decay	  kinetic	  indicated	  that	  both	  0.1	  and	  10	  μM	  TES	  severely	  increased	  baseline	  membrane	  oxidation	  in	  non-­‐activated	  human	  neutrophils	  (compared	  to	  control).	  However,	  similar	  kinetics	  of	  membrane	  oxidation	  were	  observed	  in	  control	  and	  0.1	  μM	  TES-­‐treated	  neutrophils	  after	  PMA	  activation,	  whereas	  chemical	  activation	  did	  not	  alter	  the	  baseline	  higher	  rates	  of	  membrane	  oxidation	  in	  10	  μM	  TES-­‐treated	  neutrophils.	  The	  data	  presented	  here	  support	  the	  hypothesis	  that	  TES	  exerts	  distinct	  effects	  on	  the	  membrane	  oxidation	  of	  human	  neutrophils,	  depending	  on	  its	  dose	  (here,	  102	  to	  104-­‐fold	  higher	  than	  physiological	  levels	  in	  men)	  and	  on	  PMA	  activation	  of	  the	  oxidative	  burst.	  Furthermore,	  this	  paper	  also	  presents	  an	  innovative	  application	  of	  the	  free	  radical-­‐sensitive	  probe	  C11-­‐BODIPY581/591	  for	  monitoring	  (auto-­‐induced)	  membrane	  oxidation	  as	  an	  important	  parameter	  of	  viability	  and,	  thus,	  responsiveness	  of	  immune	  cells	  in	  inflammatory	  processes.	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HEPES	  4-­‐(2-­‐hydroxyethyl)-­‐1-­‐piperazineethanesulfonic	  acid	  
PMA	  Phorbol-­‐12-­‐myristate-­‐13-­‐acetate	  
ROS/RNS	  Reactive	  oxygen/nitrogen	  species	  
TBARS	  Thiobarbituric	  acid	  reactive	  substances	  
TES	  Testosterone	  
VSMCs	  Vascular	  smooth	  muscle	  cells	  	  
Introduction	  	  Anabolic-­‐androgenic	  steroids	  (AAS)	  have	  been	  long	  used	  in	  the	  treatment	  of	  chronic	  debilitating	  illnesses,	  trauma,	  burns,	  surgery,	  and	  radiation	  therapy	  (Shehzad	  et	  al.	  2001).	  The	  desire	  for	  improved	  body	  aesthetics,	  physical	  function,	  and	  sport	  performance	  has	  also	  fueled	  anabolic	  drug	  abuse	  over	  the	  past	  50	  years	  (Hoffman	  et	  al.	  2009).	  Since	  aging	  is	  regularly	  associated	  with	  a	  gradual	  decline	  in	  circulating	  testosterone	  concentrations	  and	  decreased	  musculature	  in	  men,	  AAS	  replacement	  therapies	  have	  been	  currently	  suggested	  to	  circumvent	  the	  age-­‐related	  morbidity	  and	  cognitive	  impairment	  in	  men	  (Dillon	  et	  al.2010).	  Accordingly,	  supra-­‐physiologic	  (50	  nM	  =	  50-­‐fold	  normal)	  dosing	  of	  testosterone	  for	  eight	  continuous	  weeks	  has	  been	  shown	  protective	  to	  muscle	  mass	  and	  fatigue	  resistance	  in	  orchiectomized	  mice	  compared	  to	  sham	  operated	  animals	  (Axell	  et	  al.	  2006).	  The	  protective	  action	  of	  testosterone	  on	  skeletal	  muscle	  and	  cognitive	  capacities	  may	  in	  part	  be	  due	  to	  its	  anti-­‐inflammatory	  actions	  or	  through	  direct	  modulation	  of	  anti-­‐catabolic	  pathways	  (Thompson	  et	  al.	  2006;	  Liva	  and	  Voskuhl	  2001;	  Malkin	  et	  al.	  2004).	  On	  the	  other	  hand,	  concerns	  about	  the	  potential	  adverse	  effects	  of	  higher	  doses	  of	  testosterone	  have	  encouraged	  the	  development	  of	  strategies	  to	  define	  a	  possible	  “pharmacological	  window”	  for	  beneficial	  AAS	  effects	  in	  men.	  	  Regarding	  inflammatory	  responses,	  increased	  levels	  of	  pro-­‐inflammatory	  cytokines	  (e.g.,	  IL-­‐8,	  TNFα)	  stimulates	  the	  migration	  of	  circulating	  neutrophils	  to	  the	  inflammatory	  site,	  followed	  by	  activation	  of	  the	  membrane	  enzyme	  NADPH	  oxidase	  and	  massive	  production	  of	  reactive	  oxygen/nitrogen	  species	  (ROS/RNS)	  (Dong	  et	  al.	  2011;	  Krüeger	  et	  al.	  2009;	  Zembron-­‐Lacny	  et	  al.	  2010).	  Although	  the	  oxidative	  burst	  of	  neutrophils	  represents	  a	  key-­‐event	  in	  eliciting	  efficient	  immune	  responses,	  the	  massive	  production	  of	  ROS/RNS	  can	  also	  negatively:	  (a)	  affect	  the	  structural	  integrity	  of	  the	  neutrophil	  membrane;	  (b)	  limit	  the	  microbicidal	  and	  phagocytic	  activities	  of	  neutrophils	  due	  to	  oxidative	  modification	  of	  membrane	  proteins;	  (c)	  
induce	  apoptosis	  prematurely	  leading	  to	  cell	  degradation;	  (d)	  shorten	  the	  half-­‐life	  of	  active	  neutrophils	  in	  inflammatory	  sites;	  and,	  as	  a	  general	  effect;	  (e)	  compromise	  general	  immune	  responsiveness	  (Ottonello	  et	  al.2011).	  Lipid/membrane	  oxidation	  is	  notoriously	  recognized	  as	  a	  harmful	  event	  related	  to	  cell	  dysfunction	  and,	  thus,	  possibly	  related	  here	  to	  loss	  of	  neutrophil	  viability	  during	  inflammatory	  processes.	  Thus,	  by	  strategically	  pre-­‐attaching	  the	  free	  radical-­‐sensitive	  fluorescent	  probe	  C11-­‐BODIPY581/591	  (Drummen	  et	  al.2002)	  to	  neutrophil	  membranes,	  we	  aim	  here	  to	  investigate	  the	  effects	  of	  supra-­‐physiological	  doses	  (0.1	  and	  10	  μM)	  of	  testosterone	  on	  the	  membrane	  oxidation	  kinetics	  of	  activated	  human	  neutrophils	  in	  vitro,	  as	  an	  important	  marker	  of	  immune	  efficiency.	  Furthermore,	  this	  paper	  also	  presents	  an	  innovative	  application	  of	  C11-­‐BODIPY581/591	  for	  monitoring	  the	  progression	  of	  the	  auto-­‐induced	  membrane	  oxidation	  in	  immune	  cells.	  Proper	  methodological	  controls	  were	  performed	  with	  the	  powerful	  lipid-­‐soluble	  antioxidant	  astaxanthin	  (Barros	  et	  al.	  2001;	  Naguib	  2000)	  in	  order	  to	  check	  the	  susceptibility	  of	  neutrophil	  membranes	  to	  ROS/RNS—especially	  peroxyl	  and	  alkoxyl	  radicals,	  main	  propagating	  agents	  of	  lipid	  oxidation—and	  the	  effects	  of	  cell	  density	  to	  the	  fluorescence	  signal.	  	  
Materials	  and	  methods	  
	  
Chemicals	  	  Highly	  purified	  chemicals	  for	  usual	  solutions,	  including	  specific	  buffers,	  were	  purchased	  from	  Labsynth	  (Diadema,	  SP,	  Brazil).	  Other	  chemicals	  like	  Histopaque-­‐1077,	  dimethyl	  sulfoxide	  (DMSO),	  Triton	  X-­‐100,	  astaxanthin,	  and	  phorbol-­‐12-­‐myristate	  13-­‐acetate	  (PMA)	  were	  obtained	  from	  Sigma-­‐Aldrich	  Chemical	  Co	  (St	  Louis,	  MO,	  USA).	  The	  fluorescent	  probe	  4,4-­‐difluoro-­‐5-­‐(4-­‐phenyl-­‐1,3-­‐butadienyl)-­‐4-­‐bora-­‐3a,4a-­‐diaza-­‐s-­‐indacene-­‐3-­‐undecanoic	  acid	  (C11-­‐BODIPY581/591)	  was	  purchased	  from	  Molecular	  Probes	  (Ontario,	  Canada).	  	  
Subjects	  	  Nine	  healthy,	  untrained	  young	  men	  (undergraduate	  students	  from	  University	  Metropolitan	  of	  Santos,	  Brazil)	  volunteered	  to	  participate	  in	  this	  research.	  Subject	  (mean	  ±	  SD)	  age,	  height,	  and	  body	  mass	  were	  (23.4	  ±	  2.5)	  years	  (174.4	  ±	  7.0)	  cm,	  and	  (78.3	  ±	  7.0)	  kg,	  respectively.	  Blood	  collecting	  protocol	  and	  all	  other	  experimental	  procedures	  were	  approved	  by	  the	  Ethics	  Committee	  in	  Research	  of	  University	  Cruzeiro	  do	  Sul	  (Ethical	  Protocol	  CEP-­‐002-­‐2011),	  which	  conforms	  to	  the	  Standards	  for	  Research	  Using	  Human	  Subjects,	  Resolution	  196/96	  of	  the	  USA	  National	  Health	  Council	  of	  10/10/1996.	  	  
Human	  neutrophils	  in	  culture	  	  Blood	  samples	  (10	  mL)	  were	  drawn	  from	  the	  forearm	  cubital	  vein	  of	  volunteers	  using	  EDTA-­‐containing	  Vacutainer®	  kits.	  Heparinized	  tubes	  were	  avoided,	  since	  eventual	  iron	  contamination	  could	  accelerate	  oxidative	  degradation	  of	  samples	  (Freitas	  et	  al.	  2008).	  Blood	  samples	  were	  diluted	  in	  the	  same	  volume	  of	  phosphate	  
buffered	  saline	  solution	  (0.137	  M	  NaCl,	  2.7	  mM	  KCl,	  8.0	  mM	  Na2HPO4,	  pH	  7.4)	  and	  neutrophils	  were	  separated	  using	  Histopaque	  1077	  according	  to	  the	  manufacturer’s	  instructions	  (Sigma-­‐Aldrich,	  MO,	  USA).	  The	  plasma	  and	  intermediary	  layer	  were	  removed	  and	  both	  neutrophils	  and	  erythrocytes	  were	  collected	  from	  sediment.	  Erythrocytes	  were	  lysed	  with	  a	  hemolysis	  solution	  (150	  mM	  NH4Cl,	  10	  mM	  NaHCO3,	  0.1	  mM	  EDTA,	  pH	  7.4)	  and	  immediately	  centrifuged	  for	  10	  min	  (600g	  at	  4	  °C).	  This	  procedure	  was	  repeated	  twice	  for	  full	  red	  blood	  cell	  lyse.	  Thereafter,	  neutrophils	  were	  washed	  with	  PBS	  followed	  by	  centrifugation	  for	  10	  min	  (600g	  at	  4	  °C).	  After	  centrifugation,	  isolated	  neutrophils	  were	  maintained	  in	  RPMI-­‐1640	  medium	  supplemented	  with	  2	  mM	  glutamine,	  20	  mM	  HEPES,	  10	  %	  fetal	  calf	  serum,	  10	  U/mL	  penicillin,	  and	  10	  mg/mL	  streptomycin.	  The	  number	  of	  viable	  cells	  (>95	  %)	  was	  determined	  in	  a	  Neubauer	  chamber	  under	  an	  optical	  microscope	  by	  Trypan	  blue	  exclusion	  (Marin	  et	  al.	  2010).	  Alternatively,	  a	  second	  set	  of	  human	  neutrophils	  were	  isolated	  from	  blood	  samples	  by	  including	  a	  pre-­‐cleaning	  treatment	  with	  Dextran	  500.	  Blood	  samples	  (5	  mL)	  were	  mixed	  with	  6.7	  mL	  of	  6	  %	  non-­‐pyrogenic	  Dextran	  500	  (w/v)	  in	  sterile	  0.9	  %	  NaCl	  solution	  and	  the	  upper	  cell	  layer	  was	  transferred	  to	  a	  50-­‐mL	  polypropylene	  tube	  for	  a	  brief	  centrifugation	  (740g	  for	  10	  min,	  room	  temperature).	  Afterwards,	  supernatant	  was	  discarded	  and	  the	  total	  cell	  pellet	  was	  resuspended	  in	  sterile	  0.9	  %	  NaCl	  solution.	  Next,	  the	  diluted	  white	  blood	  cell	  suspension	  was	  carefully	  applied	  on	  top	  of	  7	  mL	  of	  Histopaque	  1077	  (in	  a	  50-­‐mL	  polypropylene	  tube),	  as	  previously	  described.	  All	  materials	  used	  for	  blood	  collection	  (syringes,	  needles,	  bottles)	  were	  disposable	  and	  handled	  by	  health/medical	  professionals	  of	  the	  ICAFE/Universidade	  Cruzeiro	  do	  Sul	  to	  prevent	  any	  potential	  physical	  complication.	  
	  
Testosterone	  treatment	  	  Neutrophils	  (2	  ×	  106	  cell/mL),	  in	  a	  RPMI-­‐1640	  medium,	  were	  treated	  with	  0.1	  and	  10	  μM	  testosterone	  (1.0	  mg/mL	  in	  1,2-­‐dimethoxyethane,	  T5411-­‐1ML,	  Sigma-­‐Aldrich),	  and	  incubated	  in	  a	  humidified	  atmosphere	  of	  5	  %	  CO2	  at	  37	  °C	  for	  24	  h,	  in	  accordance	  with	  preliminary	  studies	  (Marin	  et	  al.	  2010).	  Control	  cultures	  (treated	  with	  same	  volumes	  of	  the	  drug	  vehicle,	  1,2-­‐dimethoxyethane	  or	  DMSO)	  were	  simultaneously	  incubated	  under	  the	  same	  experimental	  conditions.	  Neither	  1,2-­‐dimethoxyethane	  nor	  DMSO	  (vehicles	  for	  TES	  administration)	  showed	  significant	  toxic	  effects	  to	  isolated	  neutrophils	  at	  concentrations	  applied	  here	  (lower	  than	  2	  %	  of	  total	  medium	  volumes).	  
	  
Control	  assays	  with	  astaxanthin	  (AST)	  	  In	  order	  to	  examine	  the	  susceptibility	  of	  neutrophil	  membranes	  to	  (auto-­‐induced)	  oxidation,	  human	  neutrophils	  in	  culture	  were	  pre-­‐loaded	  with	  5	  or	  10	  μM	  astaxanthin	  (AST),	  a	  powerful	  antioxidant	  carotenoid	  recognized	  by	  its	  highly	  specific	  scavenging	  activity	  against	  the	  main	  propagating	  agents	  of	  lipid	  oxidation	  processes:	  peroxyl	  and	  alkoxyl	  radicals	  (ROO·	  and	  RO·,	  respectively).	  Thus,	  it	  is	  expected	  that	  AST	  could	  intercept	  both	  ROO·	  and	  RO·	  radicals	  and	  prevent	  neutrophil	  membrane	  from	  oxidation	  in	  active	  neutrophils.	  Noteworthy,	  AST	  does	  
not	  affect	  sensitivity	  or	  the	  electronic	  configuration/properties	  (thus,	  fluorescence)	  when	  concomitantly	  incorporated	  with	  C11-­‐BODIPY581/591	  in	  biological	  membranes	  (Naguib	  2000).	  The	  effects	  of	  cell	  density	  (5	  ×	  105,	  1	  ×	  106,	  and	  2	  ×	  106	  cell/well)	  were	  also	  checked	  in	  control	  experiments.	  	  
C11-­‐BODIPY581/591	  loading	  in	  membranes	  	  Cultured	  neutrophils	  were	  concentrated	  by	  centrifugation	  (740g	  for	  10	  min	  at	  room	  temperature),	  resuspended	  in	  PBS	  (0.137	  M	  NaCl,	  2.7	  mM	  KCl,	  8.0	  mM	  Na2HPO4,	  pH	  7.4),	  and	  seeded	  in	  96-­‐well	  fluorescence	  microplates	  (1	  ×	  105/well).	  Subsequently,	  neutrophils	  were	  incubated	  with	  3.2	  μM	  C11-­‐BODIPY581/591	  (in	  DMSO),	  in	  the	  dark,	  at	  37	  °C	  and	  smoothly	  shaken	  for	  1	  h	  for	  adequate	  labeling,	  modifying	  the	  original	  protocol	  described	  by	  Makrigiorgos	  (1997).	  The	  probe	  C11-­‐BODIPY581/591	  is	  very	  sensitive	  to	  oxidation	  initiated	  by	  ROO·	  and	  RO·	  radicals	  (Drummen	  et	  al.	  2002).	  The	  fluorescent	  probe	  C11-­‐BODIPY581/591:	  (a)	  anchors	  with	  high	  stability	  to	  biological	  membranes	  by	  strong	  hydrophobic	  interaction	  of	  its	  undecanoic	  acid	  moiety	  with	  lipid	  bilayers;	  (b)	  shows	  good	  spectral	  separation	  of	  the	  non-­‐oxidized	  (595	  nm)	  and	  oxidized	  (520	  nm)	  forms;	  (c)	  has	  a	  good	  photo-­‐stability	  and	  displays	  very	  few	  fluorescence	  artifacts;	  (d)	  is	  virtually	  insensitive	  to	  microenvironmental	  changes,	  such	  as	  pH	  or	  solvent	  polarity;	  (e)	  once	  oxidized,	  C11-­‐BODIPY581/591	  remains	  lipophilic	  and	  does	  not	  spontaneously	  leave	  the	  lipid	  bilayer;	  (f)	  is	  not	  cytotoxic	  to	  most	  model	  mammal	  cells;	  and	  (g)	  is	  comparably	  sensitive	  to	  oxidation	  of	  common	  unsaturated	  fatty	  acids	  of	  biological	  membranes	  (Papa	  et	  al.	  1999).	  	  The	  progression	  of	  neutrophil	  membrane	  oxidation	  was	  measured	  by	  monitoring	  the	  decay	  of	  fluorescence	  emission	  at	  600	  nm	  for	  60	  min	  (excit.	  λ	  =	  575	  nm),	  after	  the	  addition	  of	  100	  ng/well	  phorbol-­‐12-­‐myristate-­‐13-­‐acetate	  (PMA),	  to	  trigger	  the	  oxidative	  burst	  in	  neutrophils.	  At	  time	  zero	  (immediately	  before	  PMA	  addition),	  fluorescence	  intensity	  was	  adjusted	  to	  1.0	  unit	  and,	  thus,	  hereafter	  defined	  as	  dimensionless	  relative	  fluorescence	  intensity	  (arbitrary	  units,	  A.U.).	  We	  assume	  that	  under	  these	  circumstances,	  the	  reaction	  of	  ROO·/RO·	  radicals	  with	  C11-­‐BODIPY581/591	  becomes	  a	  pseudo	  first-­‐order	  reaction,	  which	  is	  well	  fitted	  by	  the	  first-­‐order	  exponential	  decay	  function:	  
	  where	  y	  is	  relative	  fluorescence	  intensity,	  y	  0	  is	  relative	  fluorescence	  intensity	  at	  time	  zero	  (equals	  1.0),	  A	  1	  is	  attenuation	  factor,	  k	  is	  rate	  constant	  and	  t	  is	  time	  (min).	  
Statistical	  analyses	  Statistical	  analysis	  on	  C11-­‐BODIPY581/591	  kinetics	  was	  performed	  by	  paired	  student	  t	  test	  of	  all	  56	  data	  points,	  followed	  by	  the	  Tukey’s	  post-­‐test.	  Origin	  Pro8	  8SR0	  software	  was	  used	  for	  statistical	  analyses	  and	  graph	  preparation	  (v8.0725/B725;	  OriginLab	  Corporation,	  Northampton,	  MA,	  USA).	  
	  
Results	  Figure	  1	  illustrates	  the	  experimental	  controls	  of	  C11-­‐BODIPY581/591	  incorporated	  in	  neutrophil	  membranes.	  As	  shown	  in	  Fig.	  1a,	  different	  AST	  concentration	  did	  not	  affect	  the	  (relatively	  noisy)	  fluorescent	  signal	  of	  C11-­‐BODIPY581/591	  pre-­‐attached	  to	  membranes	  of	  non-­‐activated	  neutrophils	  (2	  ×	  106	  cell/well).	  Similar	  kinetics	  were	  obtained	  with	  lower	  density	  cultures.	  Figure	  1b	  shows	  the	  unexpected	  increase	  of	  C11-­‐BODIPY581/591fluorescence	  in	  2	  ×	  106	  cell/well	  cultures	  of	  neutrophils	  activated	  with	  PMA.	  Interestingly,	  AST	  did	  not	  show	  any	  significant	  effect	  on	  C11-­‐BODIPY581/591	  kinetics.	  When	  cell	  density	  was	  diminished	  to	  1	  ×	  106	  cell/well,	  C11-­‐BODIPY581/591	  fluorescence	  was	  apparently	  more	  responsive	  to	  AST	  concentrations,	  although	  fluorescence	  increases	  were	  still	  observed	  (Fig.	  1c).	  Finally,	  increasing	  concentrations	  of	  AST	  proportionally	  reduced	  the	  fluorescence	  decay	  rate	  of	  C11-­‐BODIPY581/591	  in	  5	  ×	  105	  neutrophil/well	  cultures,	  as	  shown	  in	  Fig.	  1d.	  It	  is	  worthy	  to	  note	  that	  a	  transition	  period	  of	  about	  9	  min	  (ca.	  500	  s)	  was	  necessary	  to	  obtain	  a	  stable	  fluorescence	  signal.	  Based	  on	  these	  results,	  further	  studies—as	  those	  under	  testosterone	  effect—were	  performed	  with	  1	  ×	  105	  neutrophil/well	  cultures,	  which	  accordingly	  provided	  more	  stable	  fluorescent	  signals	  (Figs.	  2,	  3).	  	  Based	  on	  calculated	  correlation	  indexes	  (R	  2	  >	  0.74;	  Table	  1),	  the	  first-­‐order	  exponential	  decay	  function	  adequately	  fits	  the	  fluorescence	  variation	  of	  C11-­‐BODIPY581/591	  with	  time,	  as	  a	  marker	  of	  neutrophil	  membrane	  oxidation.	  In	  the	  absence	  of	  PMA	  (non-­‐activated	  neutrophils),	  a	  discrete	  progression	  of	  membrane	  oxidation	  was	  observed	  in	  control	  cells	  (open	  circles	  in	  Fig.	  2),	  which	  suggests	  that	  the	  selected	  neutrophil	  isolation	  protocol	  adequately	  kept	  neutrophils	  in	  a	  non-­‐activated	  (rested)	  form.	  Quantitatively,	  the	  kinetic	  parameter	  k	  is	  useful	  to	  estimate	  the	  rate	  of	  lipid	  oxidation	  in	  neutrophil	  membranes	  (Table	  1).	  Figure	  2	  shows	  that	  0.1	  and	  10	  μM	  TES	  significantly	  accelerated	  basal	  membrane	  oxidation	  of	  human	  neutrophils,	  albeit	  without	  PMA	  (chemical)	  activation.	  This	  effect	  is	  apparently	  dose-­‐independent,	  although	  further	  studies	  are	  necessary	  to	  confirm	  this	  hypothesis.	  	  As	  expected,	  PMA	  addition	  to	  control	  neutrophils	  significantly	  activated	  the	  oxidative	  burst,	  as	  shown	  by	  comparing	  open	  circles	  in	  Figs.	  2	  and	  3,	  and	  based	  on	  the	  calculated	  k	  values	  in	  Table	  1	  (k	  was	  1.86-­‐fold	  lower	  in	  the	  presence	  of	  PMA	  than	  in	  control	  neutrophils).	  On	  the	  other	  hand,	  PMA	  activation	  surprisingly	  diminished	  the	  degree	  of	  membrane	  oxidation	  in	  0.1	  μM	  TES-­‐treated	  neutrophils	  compared	  to	  non-­‐activated	  cells	  (k	  was	  2.74-­‐fold	  higher	  in	  PMA-­‐activated	  neutrophils	  than	  in	  basal	  conditions),	  to	  reach	  identical	  scores	  as	  control	  neutrophils	  (Table	  1).	  Contrarily,	  PMA	  addition	  did	  not	  alter	  the	  high	  rate	  of	  oxidation	  (k)	  in	  membranes	  of	  human	  neutrophils	  pre-­‐treated	  with	  10	  μM	  TES	  for	  24	  h.	  	  
	  	  
Fig.	  1	  Experimental	  controls	  for	  C11-­‐BODIPY581/591	  oxidation	  in	  human	  neutrophils.	  a	  Baseline	  fluorescence	  of	  for	  C11-­‐BODIPY581/591	  in	  2	  ×	  106	  neutrophil/well	  cultures	  (non-­‐activated)	  in	  the	  presence	  or	  absence	  of	  5	  and	  10	  μM	  astaxanthin	  (ASTA);	  b	  Fluorescence	  kinetics	  of	  C11-­‐BODIPY581/591	  in	  2x106	  neutrophil/well	  cultures	  activated	  at	  time	  zero	  with	  100	  ng	  PMA/well	  in	  the	  presence	  or	  absence	  of	  5	  and	  10	  μM	  astaxanthin	  (ASTA);	  c	  Fluorescence	  kinetics	  of	  
C11-­‐BODIPY581/591	  in	  1	  ×	  106	  neutrophil/well	  cultures	  activated	  at	  time	  zero	  with	  100	  ng	  PMA/well	  in	  the	  presence	  or	  absence	  of	  5	  and	  10	  μM	  astaxanthin	  (ASTA);	  and	  dFluorescence	  kinetics	  of	  C11-­‐BODIPY581/591	  in	  5	  ×	  105	  neutrophil/well	  cultures	  activated	  at	  time	  zero	  with	  100	  ng	  PMA/well	  in	  the	  presence	  or	  absence	  of	  5	  and	  10	  μM	  astaxanthin	  (ASTA)	  	  
	  	  
Fig.	  2	  Kinetics	  of	  C11-­‐BODIPY581/591	  fluorescence	  in	  human	  neutrophils	  treated	  for	  24	  h	  with	  0.1	  or	  10	  μM	  testosterone	  (TES)	  in	  vitro	  	  
	  
Fig.	  3	  Kinetics	  of	  C11-­‐BODIPY581/591	  fluorescence	  in	  human	  neutrophils	  treated	  for	  24	  h	  with	  0.1	  or	  10	  μM	  testosterone	  (TES)	  in	  vitro	  and	  activated	  at	  time	  zero	  with	  100	  ng/well	  phorbol-­‐12-­‐myristate-­‐13-­‐acetate	  (PMA)	  	  
 
Table	  1	  First-­‐order	  decay	  parameters	  of	  C11-­‐BODIPY581/591	  fluorescence	  in	  resting	  and	  chemically	  activated	  (100	  ng	  PMA/105	  cells)	  human	  neutrophils	  pre-­‐treated	  in	  vitro	  with	  testosterone	  (TES)	  0.1	  or	  10	  μM	  for	  24	  h	  	  	  
	  	  
Discussion	  
Experimental	  procedures	  Independent	  to	  which	  protocol	  for	  neutrophil	  isolation	  was	  used	  (including	  pre-­‐treatment	  with	  6	  %	  Dextran	  or	  not),	  noisy	  signals	  of	  fluorescence	  were	  detected	  during	  the	  first	  5–10	  min	  after	  PMA	  activation	  of	  the	  oxidative	  burst	  (Figs.	  1,	  2,	  3).	  This	  effect	  was	  observed	  either	  when	  neutrophils	  were	  pre-­‐loaded	  with	  the	  powerful	  antioxidant	  AST	  or	  by	  TES	  addition,	  which	  suggests	  that	  structural	  changes	  in	  cell	  membrane	  following	  PMA	  activation	  are	  the	  most	  probable	  molecular	  event	  involved.	  It	  is	  also	  plausible	  that	  the	  observed	  structural	  changes	  were	  caused	  by	  the	  organic	  solvent	  DMSO,	  which	  solubilizes	  the	  activation	  factor	  PMA.	  Nevertheless,	  after	  the	  stabilization	  period,	  the	  fluorescence	  signal	  of	  C11-­‐BODIPY581/591	  was	  only	  stable	  and	  apparently	  responsive	  to	  free	  radicals	  when	  neutrophil	  density	  was	  kept	  <1	  ×	  106	  cell/well	  (Fig.	  1a–d).	  Undesirable	  iron	  contamination	  in	  samples	  (probably	  from	  hemolysis)	  should	  also	  be	  kept	  in	  mind	  when	  evaluating	  quantitative	  parameters	  of	  membrane	  oxidation	  of	  neutrophils	  and	  other	  immune	  cells	  (Haag-­‐Weber	  et	  al.	  1989).	  	  Unexpectedly,	  Fig.	  1b,	  c	  (experiments	  performed	  neutrophil	  densities	  >1	  ×	  106	  cell/well)	  revealed	  that	  C11-­‐BODIPY581/591	  fluorescence	  did	  not	  adequately	  respond	  to	  AST	  incorporation	  in	  neutrophil	  membranes.	  These	  results	  clearly	  demonstrate	  that	  the	  free	  radical-­‐sensitive	  probe	  is	  not	  stoichiometrically	  exposed	  to	  ROS/RNS	  produced	  by	  active	  neutrophils.	  Physicochemical	  changes	  in	  neutrophil	  membranes	  due	  to	  cell-­‐cell	  interactions	  (especially	  here,	  in	  high	  cell	  density	  cultures)	  might	  explain	  the	  unexpected	  pattern	  of	  fluorescence	  kinetics	  observed	  in	  Fig.	  1b,	  c.	  Fluorescent	  probes,	  including	  C11-­‐BODIPY581/591,	  normally	  change	  their	  excitation	  and	  emission	  spectra	  when	  in	  aggregate	  forms	  or	  upon	  strong	  cell-­‐cell	  interactions,	  changes	  in	  membrane	  fluidity,	  loss	  of	  lipid	  raft	  integrity,	  and/or	  mechanical	  stress	  (de	  la	  Haba	  et	  al.	  2012;	  Verstraeten	  et	  al.	  2010).	  Nevertheless,	  by	  limiting	  cell-­‐cell	  interactions	  in	  5	  ×	  105	  cell/well	  cultures,	  C11-­‐BODIPY581/591	  (at	  a	  final	  concentration	  of	  3.2	  μM)	  was	  properly	  challenged	  by	  ROS/RNS	  generated	  by	  activated	  neutrophils,	  and	  the	  dose-­‐dependent	  effect	  of	  AST	  (a	  powerful	  antioxidant)	  was	  adequately	  evidenced	  (Fig.	  1d).	  Based	  on	  these	  results,	  further	  studies—as	  those	  with	  TES—were	  performed	  with	  1	  ×	  105	  neutrophil/well	  cultures,	  which	  accordingly	  provided	  more	  stable	  fluorescent	  signals	  (Figs.	  2,	  3).	  As	  shown	  for	  other	  cell	  types,	  the	  novel	  approach	  presented	  here	  (the	  real-­‐time	  monitoring	  of	  membrane	  oxidation	  in	  human	  neutrophils	  by	  C11-­‐BODIPY581/591)	  seems	  to	  adequately	  reproduce	  the	  oxidative	  challenges	  faced	  by	  activated	  neutrophils,	  since	  PMA	  addition	  accelerated	  membrane	  oxidation	  (and	  permeability,	  Shasby	  et	  al.	  1983)	  in	  control	  neutrophils	  due	  to	  ROS/RNS	  production.	  However,	  other	  chemical	  stimuli,	  e.g.,	  granulocyte-­‐macrophage	  colony-­‐stimulating	  factor	  (GM-­‐CSF),	  lipopolysaccharide	  (LPS)	  or	  LPS	  in	  combination	  with	  interferon-­‐gamma	  (IFN-­‐γ),	  can	  also	  activate	  the	  oxidative	  burst	  in	  neutrophils	  through	  different	  signaling	  pathways	  (Atzeni	  et	  al.	  2002).	  Therefore,	  further	  studies	  evaluating	  specific	  
receptor-­‐mediated	  activation	  of	  neutrophils	  are	  required,	  since	  PMA	  is	  a	  non-­‐
specific	  polymorphonuclear	  cell	  activator	  (Paik	  et	  al.	  2005).	  
Effects	  of	  TES	  on	  membrane	  oxidation	  Testosterone	  treatment	  in	  vitro	  increased	  baseline	  membrane	  oxidation	  of	  non-­‐activated	  neutrophils	  in	  a	  dose-­‐independent	  matter,	  as	  shown	  in	  Fig.	  1	  and	  (k	  values)	  in	  Table	  1.	  However,	  we	  cannot	  confirm	  if	  this	  effect	  was	  caused	  by	  baseline	  overproduction	  of	  ROS/RNS	  in	  resting	  neutrophils	  and/or	  by	  TES-­‐mediated	  increase	  of	  antioxidant	  defenses.	  Marin	  et	  al.	  (2010)	  elegantly	  reported	  that	  pre-­‐incubation	  with	  10	  nM,	  0.1	  and	  10	  μM	  TES	  clearly	  inhibited	  superoxide	  radical	  (O	  2	  ·−	  )	  production	  in	  of	  human	  neutrophils	  after	  PMA	  activation	  (albeit,	  at	  a	  fivefold	  lower	  concentration).	  Under	  these	  circumstances,	  the	  authors	  reported	  lower	  indexes	  of	  lipid	  oxidation	  (using	  the	  thiobarbituric-­‐acid	  reactive	  substances	  assay;	  TBARS)	  in	  10	  nM	  and	  0.1	  μM	  TES-­‐treated	  cells,	  but	  not	  after	  10	  μM	  TES	  incubation.	  Although	  the	  TBARS	  assay	  is	  less	  sensitive	  than	  the	  C11-­‐BODIPY581/591	  method	  applied	  here	  (Aldini	  et	  al.	  2001),	  these	  data	  sustain	  the	  hypothesis	  that	  0.1	  μM	  TES	  mediates	  suppressive	  effects	  on	  ROS	  production	  in	  PMA-­‐activated	  neutrophils.	  Accordingly,	  Juliet	  et	  al.	  (2004)	  have	  already	  reported	  the	  suppressive	  effects	  of	  0.01	  μM	  TES	  treatment	  (tenfold	  lower	  concentration	  than	  in	  our	  study)	  on	  NADPH	  oxidase	  assemblage	  (both	  p67phox	  and	  p47phox	  expression).	  Regarding	  cellular	  mechanisms,	  Chignalia	  et	  al.	  (2012)	  demonstrated	  that	  0.1	  μM	  TES	  induces	  vascular	  smooth	  muscle	  cells	  (VSMCs)	  migration	  via	  NADPH	  oxidase-­‐derived	  ROS	  and	  c-­‐Src	  (a	  regulator	  of	  redox-­‐sensitive	  migration)	  dependent	  pathways	  in	  hypertensive	  animals.	  The	  observed	  effect	  was	  promoted	  by	  both	  genomic	  and	  non-­‐genomic	  mechanisms:	  TES	  increased	  Nox1	  and	  Nox4	  mRNA	  levels	  and	  p47phoxprotein	  expression,	  which	  are	  differentially	  regulated	  in	  VSMCs	  from	  Wistar-­‐Kyoto	  rats	  and	  hypertensive	  rats	  (Chignalia	  et	  al.	  2012).	  Thus,	  depending	  on	  the	  supra-­‐physiological	  doses	  of	  TES,	  specific	  mechanisms	  are	  apparently	  activated	  to	  influence	  redox	  metabolism	  in	  neutrophils.	  Strong	  evidence	  points	  towards	  the	  assembling	  process	  and/or	  migration	  of	  NADPH	  oxidase	  sub-­‐particles	  to	  neutrophil	  membrane	  (Juliet	  et	  al.2004;	  Chignalia	  et	  al.	  2012).	  	  Based	  on	  a	  well-­‐accepted	  hormesis	  principle,	  too	  low	  ROS/RNS	  production	  would	  limit	  crucial	  redox-­‐dependent	  processes	  such	  as	  cell	  signaling,	  H2O2-­‐mediated	  proliferation,	  and	  oxidative	  burst	  responses	  in	  polymorphonuclear	  cells,	  whereas	  excessive	  ROS/RNS	  concentrations	  would	  cause	  undesirable	  oxidative	  modifications	  to	  important	  cellular	  biomolecules	  (Valko	  et	  al.	  2007).	  Other	  authors	  have	  also	  reported	  dose-­‐dependent	  ambiguous	  effects	  of	  TES	  in	  immune	  cells,	  at	  the	  same	  micromolar	  range	  (Greabu	  et	  al.	  2003;	  Juliet	  et	  al.	  2004).	  Although	  TES	  concentrations	  reported	  here	  represent	  102	  to	  104-­‐fold	  higher	  doses	  than	  those	  physiologically	  found	  in	  average	  men	  (Shehzad	  et	  al.	  2001),	  our	  study	  demonstrates	  that	  supra-­‐physiological	  doses	  of	  TES	  can	  distinctively	  affect	  the	  progression	  of	  membrane	  oxidation	  in	  activated	  neutrophils,	  a	  molecular	  event	  that	  is	  truthfully	  related	  to	  cell	  viability,	  neutrophil	  turnover	  scores,	  and	  immune	  responsiveness.	  
 
Conclusions	  Altogether,	  our	  results	  show	  that	  supra-­‐physiological	  doses	  of	  TES	  impose	  higher	  oxidative	  conditions	  on	  circulating	  (non-­‐activated)	  neutrophils.	  This	  may	  enhance	  the	  general	  antioxidant	  capacity	  of	  circulating	  neutrophils	  as	  a	  response	  to	  the	  TES-­‐induced	  baseline	  oxidation	  of	  membranes.	  On	  the	  other	  hand,	  0.1	  μM	  TES	  treatment	  appropriately	  restored	  membrane	  oxidation	  rates	  back	  to	  those	  found	  in	  PMA-­‐activated	  control	  neutrophils,	  whereas	  the	  pre-­‐treatment	  with	  10	  μM	  TES	  (100-­‐fold	  higher	  concentration)	  sustained	  the	  high	  susceptibility	  of	  neutrophils	  to	  auto-­‐induced	  membrane	  oxidation.	  Thus,	  the	  tricky	  aspect	  of	  obtaining	  maximal	  benefits	  from	  medical	  TES	  treatments	  (e.g.,	  hormone	  reposition,	  post-­‐surgery	  recovery,	  etc.)	  is	  to	  apply	  an	  optimized	  TES	  concentration—matching	  its	  “pharmacological	  window”—that	  appropriately	  balances	  its	  required	  anabolic	  and/or	  androgenic	  effects	  with	  related	  immunosuppressive	  effects	  due	  to	  increased	  membrane	  oxidation	  in	  activated	  neutrophils.	  In	  a	  much	  worse	  scenario	  involving	  circulating	  neutrophils,	  it	  is	  worthwhile	  mentioning	  that	  TES	  benefits	  are	  normally	  obtained	  at	  nano/micro	  molar	  concentrations	  in	  plasma,	  which,	  thus,	  require	  sensitive	  methods	  to	  investigate	  such	  relevant	  physiological	  processes.	  The	  technique	  presented	  here	  represents	  a	  useful	  tool	  to	  investigate	  that	  hypothesis.	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